Ameriprise Financial Inc Pliant Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$14.14 - $19.59 $18,735 - $25,956	1,325 Added 0.36%	371,126 $5.53 Million
Q4 2023 Feb 14, 2024	SELL	$12.85 - $19.15 $29,889 - $44,542	-2,326 Reduced 0.63%	369,801 $6.7 Million
Q3 2023 Nov 14, 2023	BUY	$14.58 - $20.15 $5.43 Million - $7.5 Million	372,127 New	372,127 $6.45 Million

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.